Literature Citations
1. Inhibition of Alpha-, Beta-, Gamma-, Delta-, Zeta- and Eta-class Carbonic anhydrases from Bacteria, Fungi, Algae, Diatoms and Protozoans with Famotidine. Angeli, A., M. Pinteala, S.S. Maier, S. Del Prete, C. Capasso, B.C. Simionescu, and C.T. Supuran. Journal of Enzyme Inhibition and Medicinal Chemistry, 2019. 34(1): p. 644-650. PMID[30727781]. PMCID[PMC6366436].
[PubMed]. TB_02_2019.
2. Antimicrobial Susceptibility Testing of Mycobacteroides (Mycobacterium) abscessus Complex, Mycolicibacterium (Mycobacterium) fortuitum, and Mycobacteroides (Mycobacterium) chelonae. Aono, A., K. Morimoto, K. Chikamatsu, H. Yamada, Y. Igarashi, Y. Murase, A. Takaki, and S. Mitarai. Journal of Infection and Chemotherapy, 2019. 25(2): p. 117-123. PMID[30447882].
[PubMed]. TB_02_2019.
3. Opposing Reactions in Coenzyme a Metabolism Sensitize Mycobacterium tuberculosis to Enzyme Inhibition. Ballinger, E., J. Mosior, T. Hartman, K. Burns-Huang, B. Gold, R. Morris, L. Goullieux, I. Blanc, J. Vaubourgeix, S. Lagrange, L. Fraisse, S. Sans, C. Couturier, E. Bacque, K. Rhee, S.M. Scarry, J. Aube, G. Yang, O. Ouerfelli, D. Schnappinger, T.R. Ioerger, C.A. Engelhart, J.A. McConnell, K. McAulay, A. Fay, C. Roubert, J. Sacchettini, and C. Nathan. Science, 2019. 363(6426): eaau8959. PMID[30705156].
[PubMed]. TB_02_2019.
4. 4-Hydroxy-2-pyridone Derivatives and the delta-Pyrone Isostere as Novel Agents against Mycobacterium smegmatis Biofilm Inhibitors. Borkar, M.R., S. Nandan, H.K.M. Nagaraj, J. Puttur, J. Manniyodath, D. Chatterji, and E.C. Coutinho. Medicinal Chemistry, 2019. 15(1): p. 28-37. PMID[29793410].
[PubMed]. TB_02_2019.
5. Desertomycin G, a New Antibiotic with Activity against Mycobacterium tuberculosis and Human Breast Tumor Cell Lines Produced by Streptomyces althioticus MSM3, Isolated from the Cantabrian Sea Intertidal Macroalgae Ulva Sp. Brana, A.F., A. Sarmiento-Vizcaino, I. Perez-Victoria, J. Martin, L. Otero, J.J. Palacios-Gutierrez, J. Fernandez, Y. Mohamedi, T. Fontanil, M. Salmon, S. Cal, F. Reyes, L.A. Garcia, and G. Bianco. Marine Drugs, 2019. 17(2): E114. PMID[30759848].
[PubMed]. TB_02_2019.
6. Flavonoid Mixture Inhibits Mycobacterium tuberculosis Survival and Infectivity. Cao, R., G. Teskey, H. Islamoglu, M. Gutierrez, O. Salaiz, S. Munjal, M.P. Fraix, A. Sathananthan, D.C. Nieman, and V. Venketaraman. Molecules, 2019. 24(5): E851. PMID[30823377].
[PubMed]. TB_02_2019.
7. Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. Abscessus. Choules, M.P., N.M. Wolf, H. Lee, J.R. Anderson, E.M. Grzelak, Y. Wang, R. Ma, W. Gao, J.B. McAlpine, Y.Y. Jin, J. Cheng, H. Lee, J.W. Suh, N.M. Duc, S. Paik, J.H. Choe, E.K. Jo, C.L. Chang, J.S. Lee, B.U. Jaki, G.F. Pauli, S.G. Franzblau, and S. Cho. Antimicrobial Agents and Chemotherapy, 2019. 63(3): e02204-02218. PMID[30602512].
[PubMed]. TB_02_2019.
8. Targeting Wild-type and Drug-resistant Mycobacteria in Infected Macrophages Using Drug-coated Nanoparticles. Cotta, K.B., P. Padwal, S. Agarwal, R. Bandyopadhyaya, and S. Mehra. Journal of Chemical Technology and Biotechnology, 2019. 94(3): p. 768-776. ISI[000458295400012].
[WOS]. TB_02_2019.
9. Amino acid Based Prodrugs of a Fosmidomycin Surrogate as Antimalarial and Antitubercular Agents. Courtens, C., M. Risseeuw, G. Caljon, L. Maes, A. Martin, and S. Van Calenbergh. Bioorganic & Medicinal Chemistry, 2019. 27(5): p. 729-747. PMID[30692024].
[PubMed]. TB_02_2019.
10. Development of High Throughput Screening Methods for Inhibitors of ClpC1P1P2 from Mycobacteria tuberculosis. Fraga, H., B. Rodriguez, A. Bardera, C. Cid, T. Akopian, O. Kandror, A. Park, G. Colmenarejo, J. Lelievre, and A. Goldberg. Analytical Biochemistry, 2019. 567: p. 30-37. PMID[30543804].
[PubMed]. TB_02_2019.
11. Optimization of N-Benzyl-5-nitrofuran-2-carboxamide as an Antitubercular Agent. Gallardo-Macias, R., P. Kumar, M. Jaskowski, T. Richmann, R. Shrestha, R. Russo, E. Singleton, M.D. Zimmerman, H.P. Ho, V. Dartois, N. Connell, D. Alland, and J.S. Freundlich. Bioorganic & Medicinal Chemistry Letters, 2019. 29(4): p. 601-606. PMID[30600207]. PMCID[PMC6368976].
[PubMed]. TB_02_2019.
12. Mechanism and Resistance for Antimycobacterial Activity of a Fluoroquinophenoxazine Compound. Garcia, P.K., T. Annamalai, W. Wang, R.S. Bell, D. Le, P. Martin Pancorbo, S. Sikandar, A. Seddek, X. Yu, D. Sun, A.C. Uhlemann, P.B. Tiwari, F. Leng, and Y.C. Tse-Dinh. Plos One, 2019. 14(2): e0207733. PMID[30794538].
[PubMed]. TB_02_2019.
13. Synthesis and Mechanistic Studies of Diketo acids and Their Bioisosteres as Potential Antibacterial Agents. Hasan, P., V.K. Pillalamarri, B. Aneja, M. Irfan, M. Azam, A. Perwez, R. Maguire, U. Yadava, K. Kavanagh, C.G. Daniliuc, M.B. Ahmad, M.M.A. Rizvi, Q.M. Rizwanul Haq, A. Addlagatta, and M. Abid. European Journal of Medicinal Chemistry, 2019. 163: p. 67-82. PMID[30503944].
[PubMed]. TB_02_2019.
14. Discovery, Absolute Assignments, and Total Synthesis of Asperversiamides A-C and Their Potent Activity against Mycobacterium marinum. Hou, X.M., T.M. Liang, Z.Y. Guo, C.Y. Wang, and C.L. Shao. Chemical Communications, 2019. 55(8): p. 1104-1107. PMID[30623956].
[PubMed]. TB_02_2019.
15. Glycerol Mediated Synthesis, Biological Evaluation, and Molecular Docking Study of 4-(1H-Pyrazol-4-yl)-polyhydroquinolines as Potent Antitubercular Agents. Jamale, D.K., S.S. Undare, N.J. Valekar, A.P. Sarkate, G.B. Kolekar, and P.V. Anbhule. Journal of Heterocyclic Chemistry, 2019. 56(2): p. 608-618. ISI[000458310800026].
[WOS]. TB_02_2019.
16. Synthesis and Antitubercular Activity of Some Novel N '-Substituted benzenesulfonamide Derivatives. Joshi, S.D., D. Kumar, and S.R.P. Kumar. Indian Journal of Heterocyclic Chemistry, 2018. 28(4): p. 441-446. ISI[000457020100002].
[WOS]. TB_02_2019.
17. Structure-Activity Relationships of Wollamide Cyclic Hexapeptides with Activity against Drug-resistant and Intracellular Mycobacterium tuberculosis. Khalil, Z.G., T.A. Hill, L.M. De Leon Rodriguez, R.J. Lohman, H.N. Hoang, N. Reiling, D. Hillemann, M.A. Brimble, D.P. Fairlie, A. Blumenthal, and R.J. Capon. Antimicrobial Agents and Chemotherapy, 2019. 63(3): e01773-01718. PMID[30602509].
[PubMed]. TB_02_2019.
18. Design and Synthesis of Novel Pyrimidine Derivatives as Potent Antitubercular Agents. Liu, P., Y. Yang, Y. Tang, T. Yang, Z. Sang, Z. Liu, T. Zhang, and Y. Luo. European Journal of Medicinal Chemistry, 2019. 163: p. 169-182. PMID[30508666].
[PubMed]. TB_02_2019.
19. The Compound TB47 Is Highly Bactericidal against Mycobacterium ulcerans in a Buruli Ulcer Mouse Model. Liu, Y., Y. Gao, J. Liu, Y. Tan, Z. Liu, C. Chhotaray, H. Jiang, Z. Lu, G. Chiwala, S. Wang, G. Makafe, M.M. Islam, H.M.A. Hameed, X. Cai, C. Wang, X. Li, S. Tan, and T. Zhang. Nature Communications, 2019. 10(1): p. 524. PMID[30705268]. PMCID[PMC6355801].
[PubMed]. TB_02_2019.
20. Pyrazolo[1,5-a]pyridine Inhibitor of the Respiratory Cytochrome bcc Complex for the Treatment of Drug-resistant Tuberculosis. Lu, X., Z. Williams, K. Hards, J. Tang, C.Y. Cheung, H.L. Aung, B. Wang, Z. Liu, X. Hu, A. Lenaerts, L. Woolhiser, C. Hastings, X. Zhang, Z. Wang, K. Rhee, K. Ding, T. Zhang, and G.M. Cook. ACS Infectious Diseases, 2019. 5(2): p. 239-249. PMID[30485737].
[PubMed]. TB_02_2019.
21. Synthesis of Novel Morpholine, Thiomorpholine and N-Substituted piperazine Coupled 2-(Thiophen-2-yl)dihydroquinolines as Potent Inhibitors of Mycobacterium tuberculosis. Marvadi, S.K., V.S. Krishna, D. Sriram, and S. Kantevari. European Journal of Medicinal Chemistry, 2019. 164: p. 171-178. PMID[30594675].
[PubMed]. TB_02_2019.
22. A Protein Complex from Human Milk Enhances the Activity of Antibiotics and Drugs against Mycobacterium tuberculosis. Meikle, V., A.K. Mossberg, A. Mitra, A.P. Hakansson, and M. Niederweis. Antimicrobial Agents and Chemotherapy, 2019. 63(2): e01846-01818. PMID[30420480]. PMCID[PMC6355597].
[PubMed]. TB_02_2019.
23. Pyrazole and Imidazo[1,2-b]pyrazole Derivatives as New Potential Antituberculosis Agents. Meta, E., C. Brullo, M. Tonelli, S.G. Franzblau, Y. Wang, R. Ma, W. Baojie, B.S. Orena, M.R. Pasca, and O. Bruno. Medicinal Chemistry, 2019. 15(1): p. 17-27. PMID[29792151].
[PubMed]. TB_02_2019.
24. Inhibition of Mycothione disulphide reductase and Mycobacterial Biofilm by Selected South African Plants. Oosthuizen, C.B., N. Gasa, C.J. Hamilton, and N. Lall. South African Journal of Botany, 2019. 120: p. 291-297. ISI[000456314600039].
[WOS]. TB_02_2019.
25. Microwave-assisted Synthesis and Antituberculosis Screening of Some 4-((3-(Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-l)methyl)benzenamine Hybrids. Patil, Y., R. Shingare, A. Choudhari, D. Sarkar, and B. Madje. Journal of Heterocyclic Chemistry, 2019. 56(2): p. 434-442. ISI[000458310800008].
[WOS]. TB_02_2019.
26. Dual β-lactam Combinations Highly Active against Mycobacterium abscessus Complex In Vitro. Pandey, R., L. Chen, C. Manca, S. Jenkins, L. Glaser, C. Vinnard, G. Stone, J. Lee, B. Mathema, E.L. Nuermberger, R.A. Bonomo, and B.N. Kreiswirth. mBio, 2019. 10(1): e02895-02818. PMID[30755518]. PMCID[PMC6372805].
[PubMed]. TB_02_2019.
27. Indole-2-carboxamides Are Active against Mycobacterium abscessus in a Mouse Model of Acute Infection. Pandya, A.N., P.K. Prathipati, P. Hegde, W. Li, K.F. Graham, S. Mandal, K.M. Drescher, C.J. Destache, D. Ordway, M. Jackson, and E.J. North. Antimicrobial Agents and Chemotherapy, 2019. 63(3): e02245-02218. PMID[30602519].
[PubMed]. TB_02_2019.
28. In Vitro Activity of 12 Antimicrobial Peptides against Mycobacterium tuberculosis and Mycobacterium avium Clinical Isolates. Portell-Buj, E., A. Vergara, I. Alejo, A. Lopez-Gavin, M.R. Monte, L. San Nicolas, J. Gonzalez-Martin, and G. Tudo. Journal of Medical Microbiology, 2019. 68(2): p. 211-215. PMID[30570475].
[PubMed]. TB_02_2019.
29. Synthesis of Long-chain β-Lactones and Their Antibacterial Activities against Pathogenic Mycobacteria. Santucci, P., C. Dedaki, A. Athanasoulis, L. Gallorini, A. Munoz, S. Canaan, J.F. Cavalier, and V. Magrioti. ChemMedChem, 2019. 14(3): p. 349-358. PMID[30600911].
[PubMed]. TB_02_2019.
30. Tropidia curculioides: Secondary Metabolites and Derivatives with Antimycobacterial and Leishmanicidal Activity. Sarkar, N., B. Saha, S. Singh, and S. Ghosal. Pharmacognosy Magazine, 2018. 14(59): p. S535-S538. ISI[000456306000007].
[WOS]. TB_02_2019.
31. Design, Synthesis, and In Vitro Biological Evaluation of Novel Benzimidazole Tethered Allylidenehydrazinylmethylthiazole Derivatives as Potent Inhibitors of Mycobacterium tuberculosis. Surineni, G., Y. Gao, M. Hussain, Z. Liu, Z. Lu, C. Chhotaray, M.M. Islam, H.M.A. Hameed, and T. Zhang. MedChemComm, 2019. 10(1): p. 49-60. PMID[30774854]. PMCID[PMC6349066].
[PubMed]. TB_02_2019.
32. New Conformations of Acylation Adducts of Inhibitors of β-Lactamase from Mycobacterium tuberculosis. Tassoni, R., A. Blok, N.S. Pannu, and M. Ubbink. Biochemistry, 2019. 58(7): p. 997-1009. PMID[30632739]. PMCID[PMC6383187].
[PubMed]. TB_02_2019.
33. Design, Synthesis and Antimycobacterial Activity of Less Lipophilic Q203 Derivatives Containing Alkaline Fused Ring Moieties. Wang, A., H. Wang, Y. Geng, L. Fu, J. Gu, B. Wang, K. Lv, M. Liu, Z. Tao, C. Ma, and Y. Lu. Bioorganic & Medicinal Chemistry, 2019. 27(5): p. 813-821. PMID[30692025].
[PubMed]. TB_02_2019.
34. Pharmacophore Modeling, Synthesis, and Antibacterial Evaluation of Chalcones and Derivatives. Zhang, M., A.M. Prior, M.M. Maddox, W.J. Shen, K.E. Hevener, D.F. Bruhn, R.B. Lee, A.P. Singh, J. Reinicke, C.J. Simmons, J.G. Hurdle, R.E. Lee, and D. Sun. ACS Omega, 2018. 3(12): p. 18343-18360. PMID[30613820]. PMCID[PMC6312637].
[PubMed]. TB_02_2019.
Patent Citations
35. Novel Tetrazole Compounds and Their Use in the Treatment of Tuberculosis. Alemparte-Gallardo, C., L. Encinas, and J. Esquivias Provencio. Patent. 2019. 2018-EP72205 2019034729: 206pp.
[Patent]. TB_02_2019.
36. Preparation of Thienopyrimidine and Benzofuropyrimidine Derivatives for Use as Antimicrobial Agents.Meyers, M.J., M. Singh, C.L. Stallings, L.A. Weiss, S. Wildman, and S.D. Arnett. Patent. 2019. 2018-US42425 2019018359: 134pp.
[Patent]. TB_02_2019.
37. Novel Compounds. Porras de Francisco, E., M.J. Remuinan-Blanco, M. Bourotte, B. Deprez, G. Dequirez, and N. Willand. Patent. 2019. 2018-EP72145 2019034702: 75pp.
[Patent]. TB_02_2019.
38. Novel Compounds. Porras de Francisco, E., M.J. Remuinan-Blanco, M. Bourotte, B. Deprez, and N. Willand. Patent. 2019. 2018-EP72144 2019034701: 89pp.
[Patent]. TB_02_2019.
39. Novel Compounds. Porras de Francisco, E., M.J. Remuinan-Blanco, M. Bourotte, B. Deprez, and N. Willand. Patent. 2019. 2018-EP72143 2019034700: 43pp.
[Patent]. TB_02_2019.